Free Trial
LON:NSCI

NetScientific (NSCI) Share Price, News & Analysis

NetScientific logo

About NetScientific Stock (LON:NSCI)

Key Stats

Today's Range
N/A
50-Day Range
53.12
58
52-Week Range
N/A
Volume
4,643 shs
Average Volume
27,804 shs
Market Capitalization
£12.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NetScientific plc (AIM: NSCI) is a deep tech and life sciences VC investment group with an international portfolio of innovative companies. NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events. NetScientific differentiates itself by employing a capital-light investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio. NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.

Receive NSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NetScientific and its competitors with MarketBeat's FREE daily newsletter.

NSCI Stock News Headlines

EMV Capital PLC (EMVC)
Nvidia warning urgent
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Netscientific Share Chat (NSCI)
Q-Bot Fundraising
See More Headlines

NSCI Stock Analysis - Frequently Asked Questions

NetScientific plc (LON:NSCI) posted its quarterly earnings results on Thursday, September, 24th. The company reported ($11.00) EPS for the quarter. NetScientific had a negative net margin of 182.91% and a negative trailing twelve-month return on equity of 13.70%.

Shares of NSCI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that NetScientific investors own include AstraZeneca (AZN), Eagle Point Credit (ECC), Venture Life Group (VLG), Antero Resources (AR), AutoZone (AZO), BATM Advanced Communications (BVC) and Intel (INTC).

Company Calendar

Last Earnings
9/24/2020
Today
11/02/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

Net Income
£-2,640,000.00
Net Margins
-182.91%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.45 million
Book Value
GBX 76 per share

Miscellaneous

Free Float
N/A
Market Cap
£12.81 million
Optionable
Not Optionable
Beta
1.67
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (LON:NSCI) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners